Bovine Lipid Extract Surfactant Injection

Price 100 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Bovine Lipid Extract Surfactant Injection Specification

CAS No
Not assigned (mixture product)

Application
Hospitals, Clinical, Medical

Purity
98% - 99%

Grade
Pharmaceutical Grade

Molecular Formula
Not applicable (Mixture of natural bovine pulmonary surfactant lipids and proteins)

Formulations Type
Injectables

Formulations Form
Powder

Treatments & Functions
Treatment of Respiratory Distress Syndrome (RDS) in premature infants

Gender/Age Group
Adult, Children, Infants

Dosage Guidelines
As prescribed by physician

Volume
8 ml, 4 ml

Storage Instructions
Store in Cool

Bovine Lipid Extract Surfactant Injection Trade Information

Minimum Order Quantity
100 Boxes

FOB Port
Mundra Port

Supply Ability
100000 Boxes Per Month

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Domestic Market
All India

Certifications
ISO, GMP, WHO

About Bovine Lipid Extract Surfactant Injection

Bovine Lipid Extract Surfactant Injection

Our company is the reckoned as one of the most promising exporters of a wide stock of Bovine Lipid Extract Surfactant Injection. Procured from the most trusted vendors present in the market. This Bovine Lipid Extract Surfactant Injection is wisely formulated in compliance with FDA norms using supreme quality compounds. Before the final dispatch in the market, Bovine Lipid Extract Surfactant Injection is stringently tested on various standard quality parameters by our experts. This Bovine Lipid Extract Surfactant Injection is recommended for premature babies for the treatment of lung distress in them.

Key points: This medicine is used in the treatment of acute respiratory distress syndrome

Specifications:

Brand: Neosurf
Contain: Bovine Lipid Extract Surfactant Inj
Strength: 3ml , 5ml
Company: Cipla
Packing: Vail

Features:

Long shelf life
Reliable usage
Effectiveness

Comprehensive Clinical Solution for RDS

This surfactant injection is formulated to provide rapid and effective management of Respiratory Distress Syndrome in premature infants. Its high purity and natural composition make it a trusted choice among hospitals and clinicians seeking to improve neonatal outcomes. Suitable for a wide range of age groups, it is manufactured to stringent safety and sterility standards.

Precision Formulation and Controlled Administration

The bovine lipid extract surfactant combines essential lung lipids and critical proteins, delivered through intratracheal instillation to achieve optimal distribution within the lungs. The injection is provided as a lyophilized powder to maintain stability, and requires reconstitution with sterile water prior to use under physician guidance.

Trusted and Safe Hospital-Based Application

Packaged in vials and intended strictly for medical settings, this product meets rigorous requirements for sterility and pharmaceutical grade. It is not intended for self-administration, and dosage guidelines must be meticulously followed as prescribed by a qualified physician to ensure patient safety and product efficacy.

FAQs of Bovine Lipid Extract Surfactant Injection:

Q: How is Bovine Lipid Extract Surfactant Injection administered?

A: This medication is given via intratracheal instillation, whereby the reconstituted solution is delivered directly into the windpipe. It is administered by healthcare professionals in a hospital or clinical setting.

Q: What is the primary application of this surfactant injection?

A: Bovine Lipid Extract Surfactant Injection is mainly used to treat Respiratory Distress Syndrome (RDS) in premature infants, helping to restore lung function by replenishing essential pulmonary surfactants.

Q: When should the injection be used?

A: The injection is administered as soon as a physician diagnoses RDS in an infant or as directed by a specialist. Timely use is critical for optimal therapeutic benefit.

Q: Where should this product be stored prior to use?

A: This surfactant powder should be stored in a cool environment to ensure its stability and purity until it is ready for reconstitution and administration.

Q: What is the process for preparing the injection before use?

A: The lyophilized powder must be reconstituted with sterile water before administration. The process should be performed in a sterile environment by medical professionals as per the manufacturers instructions.

Q: Who can benefit from this treatment?

A: Premature infants suffering from RDS are the primary beneficiaries. However, the injection can be administered to adults and children if prescribed by a qualified physician for specific indications.

Q: What are the safety recommendations for use?

A: This medication is strictly for hospital or clinical application and must not be self-administered. It should only be used under the supervision of trained medical personnel.

Tell us about your requirement